# ANAPTYSBIO, INC (ANAB) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ANAPTYSBIO, INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ANAB/mda/fy2025/): filed 2026-03-03; accession 0001193125-26-088290 (https://www.sec.gov/Archives/edgar/data/1370053/000119312526088290/anab-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ANAB/mda/fy2024/): filed 2025-02-27; accession 0001370053-25-000024 (https://www.sec.gov/Archives/edgar/data/1370053/000137005325000024/anab-20241231.htm)
- [FY 2023 MD&A](/company/ANAB/mda/fy2023/): filed 2024-03-11; accession 0001370053-24-000011 (https://www.sec.gov/Archives/edgar/data/1370053/000137005324000011/anab-20231231.htm)
- [FY 2022 MD&A](/company/ANAB/mda/fy2022/): filed 2023-03-01; accession 0001370053-23-000020 (https://www.sec.gov/Archives/edgar/data/1370053/000137005323000020/anab-20221231.htm)
- [FY 2021 MD&A](/company/ANAB/mda/fy2021/): filed 2022-03-07; accession 0001370053-22-000009 (https://www.sec.gov/Archives/edgar/data/1370053/000137005322000009/anab-20211231.htm)

Back to /company/ANAB/